568 related articles for article (PubMed ID: 15837037)
1. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
3. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
4. Interventional treatments for hepatocellular carcinoma.
Guan YS; Liu Y
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):495-500. PubMed ID: 17085331
[TBL] [Abstract][Full Text] [Related]
5. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
[TBL] [Abstract][Full Text] [Related]
7. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
8. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
[TBL] [Abstract][Full Text] [Related]
11. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
[TBL] [Abstract][Full Text] [Related]
12. [Comparision of different interventional therapies for primary liver cancer].
Liu YM; Qin H; Wang CB; Fang XH; Ma QY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
[TBL] [Abstract][Full Text] [Related]
13. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
Yang P; Liang M; Zhang Y; Shen B
Adv Ther; 2008 Aug; 25(8):787-94. PubMed ID: 18670743
[TBL] [Abstract][Full Text] [Related]
15. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
Li ZR; Kang Z; Qian JS; Zhu KS; Jiang ZB; Huang MS; Guan SH; Shan H
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
Georgiades CS; Hong K; Geschwind JF
Cancer J; 2008; 14(2):117-22. PubMed ID: 18391617
[TBL] [Abstract][Full Text] [Related]
17. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
Hong K; Georgiades CS; Geschwind JF
Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
